• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.12% Nasdaq Up0.71%

    Eaton Vance Worldwide Health Sci A (ETHSX)

    13.72 Down 0.05(0.36%) Apr 24

    Profile as of Mar 30, 2015Get Profile for:
    Eaton Vance Worldwide Health Sci A
    Eaton Vance Growth TrustTwo International PlaceBoston, MA 02110
    Map
    Phone: 800-262-1122
    Fund Overview 
    Category:Health
    Fund Family:Eaton Vance
    Net Assets:1.77B
    Year-to-Date Return:8.98%
    Yield:0.00%
    Morningstar Rating:3 stars
    Fund Inception Date:Jul 26, 1985
    Morningstar Style Box 
    Health
    [View Category Definition]
    View Top Health Funds
    About the Morningstar Style Box
    Management Information 
    Samuel D. Isaly
    Lead Manager since Jul 26, 1985
    Isaly is a portfolio manager with OrbiMed Advisors. Previously, he was a president and partner with Mehta and Isaly Asset Management. From 1986 to 1989, he was a senior vice president with S.G. Warburg & Company. He also spent more than three years as a partner with Gramercy Associates, one and a half years as a vice president with Merrill Lynch & Company, and two years as a vice president with Chase Manhattan Bank.
    Investment Information 
    Min Initial Investment:1,000
    Min Initial Investment, IRA:N/A
    Min Initial Investment, AIP:1,000
    Min Subsequent Investment:N/A
    Min Subsequent Investment, IRA:N/A
    Min Subsequent Investment, AIP:50
    ETHSX can be purchased from 145 brokerages.

    Fund Summary 
    The investment seeks long-term capital growth by investing in a worldwide and diversified portfolio of health sciences companies. The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It concentrates (that is, invests at least 25% of its assets) its investments in medical research and the health care industry.

    Fund Operations 
    Last Dividend : 0.00
    Last Cap Gain (Dec 15, 2014) : 0.00
    Annual Holdings Turnover (Apr 22, 2015) : 57.00%
    Average for Category:51.10%
    Fees & Expenses 
    ExpenseETHSXCategory Avg
    Annual Report Expense Ratio (net):1.46%1.43%
    Prospectus Net Expense Ratio:1.46%N/A
    Prospectus Gross Expense Ratio:1.46%N/A
    Max 12b1 Fee:0.25%N/A
    Max Front End Sales Load:5.75%5.28%
    Max Deferred Sales Load: N/A2.37%
    3 Yr Expense Projection*:1,010603
    5 Yr Expense Projection*:1,327924
    10 Yr Expense Projection*:2,2211,815
    * Per $10,000 invested